Kevin Charles Gorman - Net Worth and Insider Trading
Kevin Charles Gorman Net Worth
The estimated net worth of Kevin Charles Gorman is at least $56 Million dollars as of 2025-04-26. Kevin Charles Gorman is the Director of Neurocrine Biosciences Inc and owns about 524,209 shares of Neurocrine Biosciences Inc (NBIX) stock worth over $56 Million. Kevin Charles Gorman is also the Director of Xencor Inc and owns about 8,392 shares of Xencor Inc (XNCR) stock worth over $88,200. Details can be seen in Kevin Charles Gorman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin Charles Gorman has not made any transactions after 2025-02-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kevin Charles Gorman
Kevin Charles Gorman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin Charles Gorman owns 2 companies in total, including Neurocrine Biosciences Inc (NBIX) , and Xencor Inc (XNCR) .
Click here to see the complete history of Kevin Charles Gorman’s form 4 insider trades.
Insider Ownership Summary of Kevin Charles Gorman
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 2025-02-13 | Sr VP & Business Development |
| XNCR | Xencor Inc | 2024-09-27 | director |
Kevin Charles Gorman Latest Holdings Summary
Kevin Charles Gorman currently owns a total of 2 stocks. Among these stocks, Kevin Charles Gorman owns 524,209 shares of Neurocrine Biosciences Inc (NBIX) as of February 13, 2025, with a value of $56 Million and a weighting of 99.84%. Kevin Charles Gorman also owns 8,392 shares of Xencor Inc (XNCR) as of September 27, 2024, with a value of $88,200 and a weighting of 0.16%.
Latest Holdings of Kevin Charles Gorman
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 2025-02-13 | 524,209 | 106.73 | 55,948,827 |
| XNCR | Xencor Inc | 2024-09-27 | 8,392 | 10.51 | 88,200 |
Holding Weightings of Kevin Charles Gorman
Kevin Charles Gorman Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin Charles Gorman has made a total of 16 transactions in Neurocrine Biosciences Inc (NBIX) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Neurocrine Biosciences Inc is the sale of 5,844 shares on February 13, 2025, which brought Kevin Charles Gorman around $681,936.
According to the SEC Form 4 filings, Kevin Charles Gorman has made a total of 2 transactions in Xencor Inc (XNCR) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Xencor Inc is the sale of 2,654 shares on September 27, 2024, which brought Kevin Charles Gorman around $54,885.
Insider Trading History of Kevin Charles Gorman
- 1
Kevin Charles Gorman Trading Performance
GuruFocus tracks the stock performance after each of Kevin Charles Gorman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin Charles Gorman is 11.61%. GuruFocus also compares Kevin Charles Gorman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin Charles Gorman within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kevin Charles Gorman's insider trading performs compared to the benchmark.
Performance of Kevin Charles Gorman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 22.18 | | | | | |
| Relative Return to S&P 500(%) | 17.9 | | | | | |
Kevin Charles Gorman Ownership Network
Ownership Network List of Kevin Charles Gorman
Ownership Network Relation of Kevin Charles Gorman
Kevin Charles Gorman Owned Company Details
What does Neurocrine Biosciences Inc do?
Who are the key executives at Neurocrine Biosciences Inc?
Kevin Charles Gorman is the Sr VP & Business Development of Neurocrine Biosciences Inc. Other key executives at Neurocrine Biosciences Inc include Chief Medical Officer Eiry Roberts , Chief Regulatory Officer Ingrid Delaet , and Chief Scientific Officer Jude Onyia .
Neurocrine Biosciences Inc (NBIX) Insider Trades Summary
Over the past 18 months, Kevin Charles Gorman made 8 insider transaction in Neurocrine Biosciences Inc (NBIX) with a net sale of 335,641. Other recent insider transactions involving Neurocrine Biosciences Inc (NBIX) include a net sale of 33,548 shares made by Ingrid Delaet , a net sale of 60,394 shares made by Darin Lippoldt , and a net sale of 119,327 shares made by Eiry Roberts .
In summary, during the past 3 months, insiders sold 207,103 shares of Neurocrine Biosciences Inc (NBIX) in total and bought 0 shares, with a net sale of 207,103 shares. During the past 18 months, 1,224,203 shares of Neurocrine Biosciences Inc (NBIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,224,203 shares.
Neurocrine Biosciences Inc (NBIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neurocrine Biosciences Inc Insider Transactions
Kevin Charles Gorman Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin Charles Gorman. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Kevin Charles Gorman's mailing address is: San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
